Why do pathological stage IA lung adenocarcinomas vary from prognosis?: A clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification

Journal of Thoracic Oncology

Volumn 8, Issue 9, 2013, Pages 1196-1202

  Zhang, Jie ^a   Wu, Jie ^a   Tan, Qiang ^a   Zhu, Lei ^a   Gao, Wen ^a  

^a SHANGHAI CHEST HOSPITAL   (China)

Author keywords

Adenocarcinoma; Classification; International Association for the Study of Lung Cancer American Thoracic Society European Respiratory Society; Lung; Pathologic tumor node metastasis Ia

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STAGING; CHINA; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; OVERALL SURVIVAL; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 84883414922     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31829f09a7     Document Type: Article

References (24)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005;117:294-299.
3. Travis WD, Brambilla E, Noguchi M, et al. The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification. J Thoracic Oncol 2011;6:244-285.
4. Ryo M, Junji Y, Genichiro I, et al. Prognostic Impact of Histology on Early-Stage Non-small Cell Lung Cancer. Chest 2011;140(1):135-145.
5. Sakao Y, Miyamoto H, Sakuraba M, et al. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components. Ann Thorac Surg 2007;83:209-214.
6. Rena O, Papalia E, Ruffini E, et al. Stage I pure bronchioloalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung. Eur J Cardiothorac Surg 2003;23:409-414.
7. Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011;24:653-664.
8. Russell PA, Wainer Z, Wright GM, Daniels M, Conron M, Williams RA. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol 2011;6:1496-1504.
9. Goldstraw P (Ed.), International Association for the Study of Lung Cancer Staging Manual in Thoracic Oncology. Orange Park, FL: Editorial Rx Press, 2009.
10. Travis WD, Brambilla E, Rami-Porta R, et al.; International Staging Committee. Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer. J Thorac Oncol 2008;3:1384-1390.
11. Tsuneyo T, Masanori T, Teruaki K, et al. Lymph node metastasis in small peripheral adenocarcinoma of the lung. J Thorac Cardiovasc Surg 1998;116:276-280.
12. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-129.
13. Gajra A, Newman N, Gamble GP, Abraham NZ, Kohman LJ, Graziano SL. Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease. Lung Cancer 2003;42:51-57.
14. Port JL, Kent MS, Korst RJ, Libby D, Pasmantier M, Altorki NK. Tumor size predicts survival within stage IA non-small cell lung cancer. Chest 2003;124:1828-1833.
15. Patz EF Jr, Rossi S, Harpole DH Jr, Herndon JE, Goodman PC. Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest 2000;117:1568-1571.
16. Read RC, Yoder G, Schaeffer RC. Survival after conservative resection for T1 N0 M0 non-small cell lung cancer. Ann Thorac Surg 1990;49:391-8; discussion 399.
17. Andrea C, Tommaso L, Luca L, et al. Impact of Size, Histology, and Gender on Stage IA Non-Small Cell Lung Cancer. Asian Cardiovasc Thorac Ann 2004;12(2):149-153.
18. Jian Z, Tomizawa Y, Yanagitani N, Iijima H, Sano T, Nakajima T. Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes. Pathol Int 2005;55:619-625.
19. Kuroda N, Hamaguchi N, Takeuchi E, Ohara M, Hirouchi T, Mizuno K. Lung adenocarcinoma with a micropapillary pattern: a clinicopathological study of 25 cases. APMIS 2006;114:381-385.
20. Amin MB, Tamboli P, Merchant SH, et al. Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol 2002;26:358-364.
21. Tsutsumida H, Yamada N, Kitajima S, et al. Micropapillary pattern (MPP) is an excellent predictor of a poor prognosis in lung adenocarcinoma, and even stronger evidence is loss of SP-A expression in MPP. AARC Meeting Abstracts, 2006;2006:1233.
22. Van Schil PE, Asamura H, Rusch VW, et al. Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Eur Respir J 2012;39:478-486.
23. Sakurai H, Asamura H, Goya T, et al.; Japanese Joint Committee for Lung Cancer Registration. Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study. J Thorac Oncol 2010;5:1594-1601.
24. Tsuboi M, Kato H, Ichinose Y, et al. Why did the gender difference influence survival in patients with completely resected stage I adenocarcinoma of the lung? J Clin Oncol, 2007;18s (25):7647.